To demonstrate this, the HIV LTR was linked to the indicator gene chloramphenicol acetyltransferase (CAT) and transfected into Vero cells with or without the trans-activating gene (tat) of HIV. Infection of these cells with HSV-1 strain KOS or temperature-sensitive mutant tsB2l or tsE6 resulted in a large increase in CAT activity in the absence of tat and further augmentation in the presence of tat. This stimulation was seen at both their permissive (34°C) and nonpermissive (39OC) temperatures, implying either that HSV-1 infection or immediateearly gene expression is all that is required. In cotransfection assays in Vero cells, cloned HSV-1 immediateearly genes ICPO and ICP4 stimulated CAT activity in the presence of tat, while ICP27 had no effect. On the other hand, in SW480 cells, ICP4 and, to a lesser extent, ICPO genes caused stimulation of CAT activity in the absence of tat. Deletion mutants within the HIV LTR showed that the target for HSV stimulation is distinct from the tat-responsive area and maps near the SPl binding sites. In HeLa cells, ICPO or ICP4 stimulated the replication of a cotransfected clone of HIV, as shown by an increase in reverse transcriptase activity in the culture supernatant.
The human immunodeficiency virus (HIV), also known as human T-lymphotropic virus type 111 or lymphadenopathyassociated virus, is a retrovirus that causes the acquired immune deficiency syndrome (2, 9, 22) . Infected individuals often do not develop overt signs or symptoms of disease for many months to years (24). During this latent or disease-free phase, low numbers of HIV-infected cells (1 in lo4 to lo6 infected lymphocytes) can be detected by in situ hybridization (15; Koenig and Gendelman, unpublished data) . The mechanisms involved in maintenance of this low level of virus expression are not understood but may, in part, involve interactions between cellular and viral regulatory elements. Elucidation of these mechanisms could help determine why HIV remains quiescent in some persons but leads to fatal disease in others.
The regulation of gene expression in HIV is complex. Transcription of viral mRNAs and progeny virion RNA originates from the viral long terminal repeat (LTR) sequences. The HIV LTR contains transcriptional regulatory sequences present in many eucaryotic and viral promoters and includes a TATA box, three SP1 binding sites (7), a core enhancer region, and a negative regulatory region (17, 19, 23) . HIV also encodes a trans-activating protein (tat) whose target is in an area of the HIV LTR known as TAR, which maps between -17 and +80 bases relative to the cap site (34) . tat exhibits multiple activities, including transcriptional activation and posttranscriptional enhancement of the expression of HIV mRNA (6, 34, 35, 38, 40, 41 ). An additional regulatory gene, the antirepression transactivator, is involved in posttranscriptional events (34).
Various stimuli, both infectious (viral infections and bacterial products) and immunologic (mitogens and growth factors), stimulate expression of HIV in cultured lympho-* Corresponding author. 37 cytes and monocytes (10, 14, 42) . We and others previously reported that herpes simplex virus (HSV) and other DNA virus sequences can stimulate expression of the HIV LTR (10, 25). HSV, a ubiquitous human pathogen that causes recurrent fever blisters, genital lesions, and other severe infections, replicates in a large number of human cell types, including human peripheral blood lymphocytes (28, 32) . HSV replication is highly regulated, with three classes of genes expressed at different stages (16). The immediate-early (alpha) genes (ICPO, ICP4, ICP22, ICP27, and ICP47) appear to be regulatory in nature. Their transcription is dependent on host cell factors but can be stimulated by a component of the infecting virion. The proteins ICPO (VmwllO) and ICP4 (Vmw175) trans-activate genes of the early (beta) and late (gamma) classes (8, 17, 29, 30) . ICP27 (Vmw63), on the other hand, appears to be involved in regulation of late protein synthesis (36).
In this paper, we demonstrate that HSV infection of cells previously transfected with HIV LTR-cat can cause over-100-fold stimulation in chloramphenicol acetyltransferase (CAT) activity. In the presence of tat, further activation of the HIV LTR is seen. Experiments using a series of deletion mutants in the HIV LTR showed that the target for HSV activation maps near the SP1 binding sites and not the TAR region. In addition, we have shown that HSV immediateearly genes ICPO and ICP4 can stimulate activation of HIV LTR-cat, as well as production of HIV reverse transcriptase activity. These effects vary in different cell lines, implying that certain cellular factors, in addition to the immediateearly genes of HSV, are involved. CAT activity in HSV-infected Vero cells transfected with HIV LTR-cat. Cells were either mock transfected (lane 1) or transfected with LTR-cat (lanes 2 to 5) or LTR-cat plus pAR(tat) (lanes 6 to 9). At 24 h posttransfection, cells were mock infected (lanes 2 and 6) or infected with 5 PFU of wild-type HSV-1 per cell (lanes 3 and 7) or 5 PFU of the temperature-sensitive mutant tsE6 per cell (lanes 4 and 8) or tsB21 (lanes 5 and 9). Cell extracts were harvested at 20 h postinfection, and CAT activity was assayed. These experiments were carried out at the permissive (34°C; panel A) and nonpermissive (39°C panel B) temperatures. CM, Chloramphenicol.
MATERIALS AND METHODS Cells and viruses. Vero cells and low-passage
cillin G (100 U/ml), streptomycin (100 ,ug/ml), and 10% fetal bovine serum. SW480 cells, a human colon carcinoma cell line (ATCC CCL228), were grown in Dulbecco minimal essential medium as previously described (1). HSV type 1 strain KOS and temperature-sensitive mutants tsB21 and tsE6 were kindly provided by Priscilla Schaffer.
Plasmids and DNA preparation. The HIV LTR was inserted upstream from the bacterial cat gene as previously described (1, 10). An HIV tat-expressing plasmid, pAR(tat), was generated from an infectious molecular clone of the virus deleted in the structural and regulatory genes (10). The HIV LTR-cat plasmids used in the deletion mutant studies were derived from a parent LTR containing sequences from -525 to +232 relative to the cap site and were generously provided by Dan Capon. These mutants have deletions within the LTR; for example, mutation dl -525/-98 lacks sequences from -525 to -98 but contains the LTR sequences from -97 to +232 inserted upstream from the cat gene (26). The HSV-containing clones ICP27 and ICPO are pMC150 and pMC151, respectively, and were gifts of Mark Challberg. The ICP4 clone, pEK1-2, was a gift of Neil DeLuca. All plasmid DNAs were prepared as described by Birnboim and Doly (3) and purified by isopycnic centrifugation in cesium chloride.
Transfections and infections. For CAT assays, cells were grown to 70% confluence in 60-mm-diameter dishes. For transfection, DNA samples were calcium phosphate coprecipitated by the method of Graham and Van der Eb (13). At 4 h after transfection, cells were washed in medium and shocked for 2to 4-min with 20% dimethyl sulfoxide. The cells were then washed and placed in growth medium. At 24 h posttransfection, the medium was removed and selected cultures were infected with 5 PFU of the appropriate HSV strain per cell. After 1 h, the cells were fed with complete medium and infection was allowed to proceed for an additional 20 h. Transfections involving the infectious clone of HIV were carried out as before but in 25-cm2 screw-cap tissue culture flasks. For these experiments, the medium was removed at 12-h intervals and stored at -70°C to be assayed later for reverse transcriptase activity.
CAT assays. Cell extracts were prepared as described by Gorman et al. (12). All reaction mixtures were corrected for protein content as determined by the method of Bradford (4). Cell extracts were preheated at 65°C for 5 min before CAT reactions. All reactions were carried out for 30 to 60 min and maintained within the linear range of the assay. Following incubation, reaction mixtures containing S ,uCi of [14C] chloramphenicol (New England Nuclear Corp., Boston, Mass.) were extracted with ethyl acetate, dried, and analyzed by ascending chromatography on silica gel thin-layer chromatography plates in chloroform-methanol (95:5) as previously described. 
RESULTS
The ability of HSV type 1 to stimulate HIV-LTR-directed gene expression was initially tested in Vero cells, a continuous line of African Green Monkey kidney cells in which HSV replicates efficiently. Cells were transfected with an LTR-cat plasmid or cotransfected with both the LTR-cat and pAR(tat) plasmids. At 24 h posttransfection, cells were infected with HSV. When cells that had been cotransfected with LTR-cat and saturating amounts of tat (10) were superinfected with HSV, a further threefold stimulation above that induced by tat alone was seen. These results were observed at both 34 and 39°C ( Fig. 1A and B , lanes 2, 6, and 7) and at 37°C (data not shown). Infection of cells containing LTR-cat by temperature-sensitive mutants of HSV produced comparable levels of cat stimulation at both the permissive (34°C) and nonpermissive (39°C) temperatures. VOL. 61, 1987 Infection with tsE6, which is defective in the immediateearly regulatory protein ICP27, and infection with tsB21, which is defective in the immediate-early regulatory protein ICP4, stimulated the HIV promoter to similar degrees ( Fig.  1A and B, lanes 4 and 5) , and further augmentation was seen in the presence of tat (lanes 8 and 9).
To determine which HSV gene products play a role in this stimulatory effect, clones containing individual HSV immediate-early genes were transfected into Vero cells, and Fig. 2 shows their effect on HIV LTR-cat expression. Cells were cotransfected with HIV LTR-cat and either pAR(tat), ICP0, ICP4, or ICP27 or with a combination of pAR(tat) and the individual HSV immediate-early genes. ICP0, 1CP4, or ICP27 had no effect on cat expression in the absence of tat. In the presence of pAR(tat), ICP4 and ICP0 produced a three-to fourfold stimulatory effect on LTR-cat expression above that seen with pAR(tat) alone, while ICP27 had no effect. These results differ from those seen in SW480 cells, in which ICP4 showed a marked stimulatory effect on CAT activity, while ICPO and ICP27 produced little and r effect, respectively (Fig. 3) .
To identify the HIV LTR sequences which respond to HSV activation, a series of LTR-cat deletion mutations from the 5' and 3' ends of pLTR (-525/+232 LTR sequences) (26) were tested for their ability to be stimulated by HSV infection. Figure 4 shows the entire sequence of the HIV LTR and indicates many of its known regulatory elements (26, 34, 35, (37) (38) (39) . The LTR sequences deleted in each construct are noted by black bars. Table 1 displays the basal levels of expression of the pLTR-cat deletion constructs in Vero cells. Plasmids with sequences deleted between -5251-77 and -525/-30, which remove the SP1 binding sites, had reduced basal levels of expression. Figure 5A ( and Table 1 ) demonstrates the effect of tat cotransfection on these mutations. Two areas of the LTR seem to be necessary for optimal activation by tat. Deletions within the TAR region (-17/+80) had a profound effect on the ability of tat to stimulate LTR-cat expression (Fig. SA, lanes 12 to 14;  Table 1 ). Deletions removing the SP1 binding sites (Fig. SA,  lanes 5 to 8; Table 1 ) reduced the level of tat activation from over 100-fold to 2-to 5-fold, in agreement with Muesing et al. (26) . Mutation dl +55/+232 (Fig. SA, lane 11) showed reduced activation by tat, while mutations dl +32/+232, dl +23/+232, and dl +6/+232 (Fig. SA, lanes 12 to 14) were not activated by tat. Figure SB (and Table 1 ) demonstrates the effect of HSV infection on cells transfected with pLTR-cat and the series of deletion mutations. Lanes 10 to 14 show that, when infected with HSV, cells transfected by plasmids with deletions in which the entire TAR region was removed showed levels of CAT activity similar to those of undeleted LTR-cat. There was an 80 to 100% decrease in CAT activity in cells transfected with plasmids containing deletions that extend into the SP1 binding sites and then infected with HSV (Fig. 5B, lanes 6 to 8) . All other mutations showed greater than 100-fold activation by HSV infection. Table 1 shows the percent acetylation of chloramphenicol from Fig. 5A and B .
The experiments with HIV LTR-cat constructions demonstrated the stimulatory effects of HSV on HIV LTR activity and allowed identification of the HSV genes and HIV regulatory sequences involved. To determine whether the effects of HSV activation on the LTR-cat constructs promote the replication of HIV, an infectious clone of HIV was cotransfected into HeLa cells with the individual immediate-early genes of HSV. Figure 6 shows the effect on HIV replication of clones containing the individual HSV immediate-early gene products ICPO, ICP4, and ICP27 and an HSV-1 DNA clone (pEcoC) that contains all three immediate-early genes (EcoRI-C). Reverse transcriptase activity in the supernatants of HeLa cell cultures was assayed. Beginning at 24 h posttransfection, reverse transcriptase activity could be detected easily, whereas mock-infected cultures had no activity (Fig. 6, lanes 1 and 2) . Cotransfection of cells with HSV, pEcoC, or the clones containing ICP4 or ICPO had a fiveto eightfold stimulatory effect on reverse transcriptase expression (lanes 3, 5, and 6), while ICP27 had no effect. These data are consistent with those of Fig. 2 and 3 , showing the stimulatory effects of both ICP4 and ICPO. FIG. 5 . The effect of pAR(tat) cotransfection or HSV infection on the expression of cat by HIV LTR-cat deletion mutants. Vero cells were transfected with LTR-cat (lanes 1 and 2) or the series of 5' and 3' LTR-cat deletion mutants (lanes 3 to 14). Panel A shows the results of CAT assays when pAR(tat) was cotransfected with the LTR-cat constructs, and panel B shows the results of HSV infection (5 PFU per cell) on cells previously (24 h) transfected with the HIV LTR-cat constructs.
HSV Infection
LTR-cat RNA were detected. The ability of herpes simplex virus to activate an HIV LTR integrated into Vero cells has also been reported (25).
The data presented here indicate that individual HSV gene products can participate in LTR activation and the mechanism of activation may vary in different cell lines. The observation that ICP4 is able to induce activation of HIV LTR-cat in SW480 but not in Vero cells suggests that SW480 cells already contain a cellular protein(s) that is otherwise not present in Vero cells. Such a cellular protein would be required for activation of the LTR by the cloned immediateearly genes of HSV. The fact that HIV-LTR activation by HSV infection occurs in Vero cells in the absence of tat implies that HSV codes for, or introduces into the cell, a protein that induces this putative cellular factor. Productive replication of HSV is not necessary to induce this factor, since ts mutants still activate the HIV LTR at the nonpermissive temperature. Under these conditions, even though the virus does not replicate, all other immediate-early gene products are expressed and the trans-activating virion component a-trans-inducing factor is introduced into the cell. This may be responsible for the induction of this putative cellular protein.
The observation that transfection of a tat-negative proviral DNA results in some progeny virus production in SW480 cells, but much less in Vero cells, is also consistent with the hypothesis that SW480 cells contain a cellular factor(s) not found in Vero cells which affects LTR-directed viral gene synthesis (H.E.G., unpublished data). It has been postulated that HSV ICP4 trans-activates HSV early genes by interacting with a cellular protein which in turn binds to sequences within HSV early gene promoters (21). Infection of cells with HSV may induce a number of cellular transcription factors that are also necessary for HIV LTR activation. SP1 and NF-kB are two such transcription-activating proteins that are known to bind to the HIV LTR (18, 27) . Three SP1 binding sites have been mapped to the area between -46 and -78, and deletions encompassing this region fail to demonstrate activation by HSV. Therefore, SP1 may be in part responsible for the HSV effect. Two NF-kB binding sites have been mapped to -80 to -92 and -96 to -106, both in J. VIROL. 
